glp-1 receptor agonist with dpp-4 inhibitor combination not recommended versus and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Role of DPP-4 Inhibitors in

Supplementary material The Supplementary Material for this article can be found online at: Abbreviations GLP-1RA, glucagon-like peptide-1 receptor agonists

Important aspects to be considered are (1) their long half-lives, (2) the capacity of GLP-1 receptor agonism to slow gastric emptying even at physiological GLP-1 concentrations, (c) tachyphylaxis observed with prolonged treatment, and (d) the limited effect on gastric emptying in individuals with slow gastric emptying before initiating treatment

Phase 3 trials for obesity and weight-related conditions are enrolling patients

The condition was gradually resolved once the patient stopped taking the drug

Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus